ClinicalTrials.gg
Enrolling by invitationNCT07816861Updated Sep 14, 2026

Y Yoga Works: Effects of Acute Yoga on Anxiety, Affect, & Cognition

An interventional study of Integrated Yoga and Yoga Postures in Anxiety, Cognition and Affect, sponsored by University of Illinois at Chicago. Enrolling by invitation at 2 sites in United States. Open to female participants aged 17 Years and older. Per ClinicalTrials.gov, last updated 2026-09-14.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by University of Illinois at Chicago · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled May 2025, registered Sep 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
17 Years and older
Sex
Female
01

Study summary

The goal of this research is to determine what components of an integrated yoga practice that influence anxiety, cognition, and affect among highly anxious college females. Participants will go through four sessions and will experience all parts of a yoga practice.

Read the detailed description

The goal of this research is to determine what components of an integrated yoga practice that influence anxiety, cognition, and affect. Anxiety disorders are the most common class of mental disorders, affecting about 1 in 5 adults in the U.S. (Kessler et al., 2005). Additionally, females are significantly more likely than males to develop an anxiety disorder throughout the lifespan (Bruce et al., 2005). Yoga in general has been shown to have a substantial number of benefits on mental health and cognition. However, there is little to no research on what parts of yoga are working to achieve positive effects. A total of 60 highly anxious female college students will experience all the following conditions: integrated yoga (a combination of postures, breathwork, and meditation), yoga postures only, breathwork/meditation only, watching a yoga documentary. Before and after each session, we will assess the effects of all conditions on anxiety, cognition, and affect.

02

Conditions studied

  • Anxiety
  • Cognition
  • Affect

Browse trials for

03

In context

Anxiety Disorders Unverified

7,207 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's planned enrollment of 60 is below the median of 80 across 6,062 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University of Illinois at Chicago is the lead sponsor of 504 studies on the registry; 119 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
17 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • college student
  • study over 14 hours
  • highly anxious
  • must identify as a female

Exclusion criteria

Exclusion Criteria:

  • is not a college student
  • does not study 14 hours or more
  • is not highly anxious
  • identifies as a male
  • is under the age of 17
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Integrated Yoga

    Participants will do a session of integrated yoga.

    Behavioral: Integrated Yoga

  • Experimental
    Yoga Postures

    Participants will do a session of only yoga postures.

    Behavioral: Yoga Postures

  • Experimental
    Breathwork/Meditation

    Participants will do a session of guided breathwork and meditation

    Behavioral: Breathwork/Meditation

  • Experimental
    Documentary

    Participants will watch a documentary.

    Behavioral: Documentary

Interventions

  • BehavioralIntegrated Yoga

    Participants will complete breathwork, meditation, and yoga postures.

  • BehavioralYoga Postures

    Participants will complete yoga postures.

  • BehavioralBreathwork/Meditation

    Participants will complete breathwork and meditation.

  • BehavioralDocumentary

    Participants will watch a yoga documentary.

06

What researchers measure

Primary outcomes

  1. Anxiety

    State Anxiety will be measured by the state portion of the State-Trait Anxiety Index.

    Time frame: Immediately before and immediately after each of four study sessions, completed over either 2 or 4 weeks.

Secondary outcomes

  1. Cognition - Inhibition

    Inhibition will be measured by the Flanker Task.

    Time frame: Immediately before and immediately after each of four study sessions, completed over either 2 or 4 weeks.

  2. Affect

    Affect will be measured by the Activation Deactivation Adjective Checklist.

    Time frame: Immediately before and immediately after each of four study sessions, completed over either 2 or 4 weeks.

  3. Cognition - Working Memory

    Working memory will be measured by the Digit Symbol Substitution Test.

    Time frame: Immediately before and immediately after each of four study sessions, completed over either 2 or 4 weeks.

07

Study locations

2 sites
  • UIC Disability, Health, and Social Policy Building
    Chicago, Illinois 60608, United States
  • UIC Physical Education Building
    Chicago, Illinois 60612, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Nov 2026, 18 months after the start.

Of 3,841 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 18 months is above that.

Counting every sponsor, half of 3,943 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2025
First posted
Sep 14, 2026
StartActual
May 15, 2025
Primary completionEst.
Nov 15, 2026
CompletionEst.
Mar 25, 2027
Last update
Sep 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07816861
Responsible party
Sponsor
First posted
Sep 14, 2026
Start date
May 15, 2025
Primary completion
Nov 15, 2026 (estimated)
Completion
Mar 25, 2027 (estimated)
Last update
Sep 14, 2026

Study contacts

Eduardo E Bustmante, PhD
study chair · University of Illinois at Chicago

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion